DNAPrint Genomics, Inc. (DNAG) Research

DNAPrint Genomics, Inc. focuses on pioneering and distributing genetic analysis solutions and services. Their product portfolio includes AncestryByDNA, a comprehensive chromosomal assay for tracing genetic lineage, and EurasianDNA, designed to identify specific European ancestral subdivisions. They also offer EuropeanDNA, which outlines an individual's fundamental continental European heritage. In forensic science, DNAWitness assists in determining genetic background from crime scene samples, while RETINOME is utilized by detectives to construct physical traits, such as eye color, from DNA evidence or human remains. Furthermore, the company provides the GenomeLab SNPstream Genotyping System, recognized for its high genotyping throughput, multiplexing capabilities, and efficient reagent usage. DNAPrint Genomics caters to diverse clients in fields like forensic investigation, genealogical exploration, consumer products, and pharmaceutical research. Originally incorporated in 1983 as Lexington Energy, Inc., the company operates from Sarasota, Florida, with an international presence through a subsidiary in Leverkusen, Germany.

Market snapshot

Symbol
DNAG
Price
$0.00
Day change
0.00%
Market cap
$12.9K
P/E ratio
-0.00x
52-week range
0.000001-0.00002
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • AVAX Technologies, Inc. (AVXT)
  • Braxia Scientific Corp. (BRAXF)
  • Interpharm Holdings, Inc. (IPAH)
  • Jack Nathan Medical Corp. (JNHMF)
  • LadRx Corporation (LADX)
  • Manhattan Scientifics, Inc. (MHTX)
  • Mobile Lads Corp. (MOBO)
  • Mera Pharmaceuticals, Inc. (MRPI)

Recent insider activity

  • GABRIEL RICHARD L — A-Award (20000000 shares) on 2007-04-27

Open DNAPrint Genomics, Inc. (DNAG) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.